SNSmith & Nephew plc
1050.00GBP-2.19%Mkt Cap: 11.52B $P/E: 19.88

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three seg…

Key Statistics

Company
Market Cap11.52B $
Enterprise Value15.61B $
Revenue (TTM)8.08B $
Gross Profit5.38B $
Net Income (TTM)801.63M $
Revenue/Share9.448 USD
Last Price1050.00 GBP
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17.0K
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINGB0009223206
Valuation
P/E (Trailing)19.88
P/E (Forward)11.80
PEG1.23
EV/EBITDA8.80
EV/Revenue1.93
P/S1.40
P/B2.34
EPS (TTM)0.54
EPS (Forward)0.89
52W Range
1050.000% of range1441.50
52W High1441.50 GBP
52W Low1050.00 GBP
Profitability
Gross Margin68.01%
Oper. Margin14.47%
EBITDA Margin21.94%
Profit Margin10.14%
ROE11.82%
ROA5.98%
Growth
Revenue Growth4.60%
Earnings Growth5.70%
Cash Flow & Leverage
Operating CF1.65B $
CapEx (TTM)555.37M $
FCF Margin16.81%
FCF Yield11.79%
Net Debt3.89B $
Net Debt/EBITDA2.19
Balance Sheet
Debt/Equity0.63
Current Ratio2.14
Quick Ratio1.11
Book Value/Sh4.496 GBP
Cash/Share0.8860 GBP
Dividends
Fwd Div Rate0.2900 GBP
Trail. Div Rate0.3970 GBP
Div. Yield2.75%
5Y Avg Yield2.60%
Payout Ratio52.45%
Ex-Div DateOct 1, 2026
Pay Date
Splits
Last Split9:11
Split DateAug 7, 2000
Analyst Consensus
Rating2.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)1286.25 GBP
Upside (mean)+22.5%
Target Range1035.43 GBP1520.63 GBP
GBP1035.43+22.5% to meanGBP1520.63
# Analysts17
Ownership
Shares Out.837.01M
Float841.93M
Insiders0.24%
Institutions73.14%
Technical
SMA 501131.10 (-7.2%)
SMA 2001199.16 (-12.4%)
Beta0.69
S&P 52W Chg18.16%
Avg Vol (30d)2.74M
Avg Vol (10d)3.09M
Technical Indicators
RSI (14)39.9
MACD-15.8607
MACD Signal-8.4292
MACD Hist.-7.4315
BB Upper1215.49 GBP
BB Middle1129.55 GBP
BB Lower1043.61 GBP
BB Width15.22%
ATR (14)32.14 GBP
Vol Ratio (20d)1.28x